Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 18;401(1):143-163.
doi: 10.1515/hsz-2019-0330.

The Ras switch in structural and historical perspective

Affiliations
Free article
Review

The Ras switch in structural and historical perspective

Raphael Gasper et al. Biol Chem. .
Free article

Abstract

Since its discovery as an oncogene more than 40 years ago, Ras has been and still is in the focus of many academic and pharmaceutical labs around the world. A huge amount of work has accumulated on its biology. However, many questions about the role of the different Ras isoforms in health and disease still exist and a full understanding will require more intensive work in the future. Here we try to survey some of the structural findings in a historical perspective and how it has influenced our understanding of structure-function and mechanistic relationships of Ras and its interactions. The structures show that Ras is a stable molecular machine that uses the dynamics of its switch regions for the interaction with all regulators and effectors. This conformational flexibility has been used to create small molecule drug candidates against this important oncoprotein.

Keywords: GAP; GEF; Ras; effector; switch regions.

PubMed Disclaimer

References

    1. Ahearn, I.M., Haigis, K., Bar-Sagi, D., and Philips, M.R. (2011). Regulating the regulator: posttranslational modification of RAS. Nat. Rev. Mol. Cell. Biol. 13, 39–51.
    1. Ahmadian, M.R., Stege, P., Scheffzek, K., and Wittinghofer, A. (1997). Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nat. Struct. Biol. 4, 686–689.
    1. Aoki, Y., Niihori, T., Kawame, H., Kurosawa, K., and Ohashi, H. (2005). Germline mutations in HRAS protooncogene cause Costello syndrome. Nat. Genet. 37, 1038–1040.
    1. Bandaru, P., Shah, N.H., Neel, H., Bhattacharyya, M., Barton, J.P., Kondo, Y., Cofsky, J.C., Gee, C.L., Chakraborty, A.K., Kortemme, T., et al. (2017). Deconstruction of the Ras switching cycle through saturation mutagenesis. eLife 6, e27810.
    1. Bery, N., Cruz-Migoni, A., Bataille, C.J.R., Quevedo, C.E., Tulmin, H., Miller, A., Russell, A., Phillips, S.E., Carr, S.B., and Rabbitts, T.H. (2018). BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions. eLIFE 7, e37122.

LinkOut - more resources